Cytovale logo

Cytovale

Healthcare & Life Sciences

Recent Finacing

Series D

Recent Raise

$100M


Cytovale is a medical diagnostics company that develops rapid diagnostic tools for early detection of sepsis.

Total Funding

$184M

Headquarters

San Francisco, USA

Founded

N/A

Focus Areas

Medical diagnostics
early detection
rapid diagnostic tool
sepsis
FDA-cleared
healthcare

Investors

Global Health Investment Corporation logo
Norwest Venture Partners logo
Sands Capital logo
Canada Pension Plan Investment Board logo
Breakout Ventures logo